Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Publications
2012
Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs
Civil Society Calls on Members of the European Parliament to Condemn ACTA
Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby
Heading ACTA and Access to Medicines: Flawed Process, Rationale and Agreement
Protect Access to Medicines: Say “No” to ACTA
Business Conduct Guidelines
Complaints Procedure (EN)
Procedimiento de Querellas
Klachtenprocedure (Complaints Procedure – Dutch)
Unlocking the Mysteries of Access to Clinical Trials Data in the EU
Call to EU Leadership on Global Health Research & Development
2011
Statement on Medicines Patent Pool
Universal Access to Medicines for Non-Communicable Diseases
Drop in Pay-for-Delay Good for Access to Medicines in Europe
Resolution on Innovation and Access to Medical Technologies
Uso Racional: La influencia de la publicidad en el uso del medicamento
Statement on Conflicts of Interests delivered at WHA
Statement on EU India and EU Mercosur Free-Trade Negotiations
Medicines pay-for-delay back under the microscope
Transparency of European Medicines Regulation
2010